Dernières nouvelles pour Coincheck Group (NASDAQ:CNCK) Stock

Coincheck Group NV is a digital asset trading service company. It operates multi-cryptocurrency marketplaces and crypto asset exchanges in Japan and marketplace and exchange platforms on which diverse cryptocurrencies, including Bitcoin and Ethereum, are held and exchanged, and offering other retail-focused crypto services.

Coincheck Group NV

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer recommended buying Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>).
On Wednesday, JPMorgan analyst Doug Anmuth maintained Netflix with an Overweight and raised the <a href="https://www.benzinga.com/quote/NFLX/analyst-ratings">price target from $850 to $1,010.</a>
 &#8220;It is absolutely true that they're not doing as well as Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>),&#8221; Cramer said when asked about Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>). &#8220;But can we just remember Lisa Su has built an amazing company?&#8221; He recommended buying the stock, saying that the stock is &#8220;actually cheap.&#8221;
On Monday, AMD named Tim Keating as senior vice president, Government Relations and Regulatory Affairs.
Cramer said he prefers Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>) over Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>). He added, &#8220;I don't want you to sell Constellation Energy, it has a habit of bouncing back because it's really involved in the data center, but it has got way too much volatility for me.&#8221;
On Nov. 22, Morgan Stanley analyst David Arcaro maintained Constellation Energy with an Overweight and lowered the price target from $323 to $322.
&#8220;Even with the talc litigation, I do want to buy it down here,&#8221; Cramer said when asked about Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>).
On Wednesday, Citigroup analyst Joanne Wuensch maintained Johnson &amp; Johnson with a Buy and lowered the price target from $185 to $175.
Rubrik, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) is a &#8220;very good&#8221; company, Cramer said. &#8220;The stock has been straight up. And, I've got to tell you, after that last quarter, I understand why it's straight up. It was probably mispriced when it came public.&#8221;
On Dec. 5, Rubrik posted better-than-expected quarterly results.
When asked about JD.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), he said, &#8220;It's too much of a stretch for me.&#8221;
On Monday, Bernstein analyst Robin Zhu upgraded JD.com from Market Perform to Outperform and raised the price target from $43 to $46.
Price Action:
<ul>
<li>AMD shares gained 1.9% to settle at $130.15 on Wednesday.</li>
<li>Constellation Energy shares gained 1.8% to close at $236.60.</li>
<li>Rubrik shares gained 1.7% to settle at $70.42 on Wednesday.</li>
<li>JD.Com shares fell 3.4% to $38.21 on Wednesday.</li>
<li>Johnson &amp; Johnson shares fell 1.7% to close at $146.64 on Wednesday.</li>
<li>Netflix shares gained 2.5% to settle at $936.56 on Wednesday.</li>
</ul>
Read Next:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>
Image: Shutterstock

Long Ideas

News

Markets

Media

Trading Ideas

NFLX

NVDA

RBRK

Jim Cramer Says This CEO 'Built An Amazing Company,' Recommends Buying Netflix

Ciena Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) reported a fiscal fourth-quarter 2024 revenue decline of 0.5% year-on-year to $1.124 billion, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42457276/ciena-reports-fiscal-fourth-quarter-2024-financial-results" rel="noreferrer noopener">analyst consensus&nbsp;estimate of $1.104 billion</a>.
The American telecommunications networking equipment and software services supplier reported adjusted EPS of $0.54, <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">missing the&nbsp;analyst consensus estimate of $0.66</a>. The stock fell after the print, but it recouped losses and traded higher in the premarket session.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/legal/24/12/42444266/nvidia-loses-supreme-court-appeal-faces-continued-legal-battle-over-cryptocurrency-disclosure" rel="noreferrer noopener">Nvidia Loses Supreme Court Appeal, Faces Continued Legal Battle Over Cryptocurrency Disclosure</a>
Segments: Total Networking Platforms revenue declined by 2.0% Y/Y to $859.0 million, and Total Global Services decreased by 5.6% Y/Y to $142.0 million.
Margins: The adjusted gross margin declined by 210 bps to 41.6%, and the adjusted operating margin decreased by 380 bps to 10.0%. Two 10%-plus customers represented a total of 31.2% of revenue.
Ciena held $1.33 billion in cash and equivalents and generated $349.3 million in operating cash flow.
The company bought back approximately 2.1 million shares of common stock for an aggregate price of $132.0 million during the quarter.
Chair Transition: Ciena named Lawton W. Fitt as independent Chair of Ciena&#8217;s Board, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42457315/ciena-announces-lawton-w-fitt-as-independent-chair-of-board-of-directors" rel="noreferrer noopener">effective December 11, 2024</a>, taking over from Patrick H. Nettles, Ph.D., who retired.&nbsp; Nettles will continue as a director to ensure a seamless transition.
CEO Gary Smith noted that the quarterly revenue and strong order flow reflect the company&#8217;s significant increasing technology leadership and positive industry dynamics. As Cloud and AI drive bandwidth demand across the network, Smith noted that Ciena is positioned for accelerated revenue growth and market share expansion.
Ciena&nbsp;stock surged over 62% year-to-date. At least 4 Wall Street firms, including Stifel, Citigroup, Rosenblatt, and Needham, <a target="_blank" href="https://www.benzinga.com/quote/CIEN/analyst-ratings" rel="noreferrer noopener">raised their price targets</a> on the stock in December 2024. Three of them have a Buy rating on the stock.
Price Action: CIEN stock is up 8.13% at $79.16 premarket at the last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42439924/match-group-under-pressure-to-deliver-strategy-for-tinders-struggles-and-hinge-growth-at-investor-meeting" target="_blank" rel="noreferrer noopener">Match Group Faces Investor Scrutiny Over Tinder Woes, Hinge Expansion Plans</a></li>
</ul>

Earnings

Management

Movers

Tech

CIEN

Ciena Q4 Earnings: Profit Misses Expectations, Margins Decline, Names New Chair

U.S. stock futures were lower this morning, with the Nasdaq futures falling around 50 points on Thursday.
Shares of Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) fell sharply in today's pre-market trading following the release of <a href="https://www.benzinga.com/markets/equities/24/12/42458235/adobe-shares-plunges-over-11-after-disappointing-revenue-forecast">quarterly results</a>.
Adobe posted better-than-expected earnings and sales results for its fourth quarter. The company said it expects first-quarter revenue to be in the range of $5.63 billion to $5.68 billion versus estimates of $5.73 billion. The company anticipates first-quarter adjusted earnings of $4.95 to $5 per share versus estimates of $4.95 per share.
Adobe shares dipped 10% to $495.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Keros Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) shares tumbled 72% to $19.23 in pre-market trading after the company issued an update on the Phase 2 TROPOS trial.</li>
<li>Primis Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRST#NASDAQ">FRST</a>) dipped 20.1% to $10.01 in pre-market trading.</li>
<li>The Lovesac Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOVE#NASDAQ">LOVE</a>) shares fell 19.9% to $30.20 in pre-market trading after the company posted weak quarterly sales and lowered FY25 forecast.</li>
<li>Contineum Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) fell 12.3% to $12.50 in pre-market trading.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) dipped 9.1% to $6.71 in pre-market trading after gaining around 14% on Wednesday.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) shares declined 7.3% to $11.61 in pre-market trading.</li>
<li>ADS-TEC Energy PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSE#NASDAQ">ADSE</a>) fell 5.2% to $13.25 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>

Pre-Market Outlook

ADBE

ADSE

CGEM

CTNM

FRST

KROS

LOVE

RGTI

Adobe, Keros Therapeutics, Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

<ul>
<li>Company on track to deliver five Investigational New Drug (IND) applications as part of ‘5 by 5' solid tumor strategy 18 months ahead of original target</li>
<li>Nomination of ZW209, a novel trispecific T cell engager, as fifth development candidate in the Company's solid tumor portfolio</li>
<li>Expansion into autoimmune and inflammatory diseases (AIID) and hematology oncology leverages the Company's clinically validated Azymetric&#x2122;&nbsp;technology platform and expertise in multispecific therapeutics</li>
<li>ZW1528, the Company's first development candidate in AIID, demonstrates dual blockade of two complementary pathways of respiratory inflammation and offers potential benefit in mixed-type chronic obstructive pulmonary disease (COPD)</li>
<li>In-person and virtual R&amp;D Day featuring Zymeworks research leadership and key opinion leaders to be held today at 8:30 am Eastern Standard Time (EST) &nbsp;</li>
</ul>
VANCOUVER, British Columbia, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYME#NASDAQ">ZYME</a>), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced highlights from its R&amp;D Day reviewing the Company's development progress on its wholly-owned pipeline assets and expansion into new therapeutic areas in hematological cancers and autoimmune and inflammatory diseases (AIID).

Biotech

General

ZYME

Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress In Oncology Programs And Expansion Into Autoimmune And Inflammatory Diseases December 12, 2024 At 8:30 am EST

A new cryptocurrency venture associated with U.S. President-elect&nbsp;Donald Trump&nbsp;has reportedly partnered with a platform linked to controversial activities. This partnership has raised eyebrows due to the platform&#8217;s alleged connections with criminal groups.
What Happened:&nbsp;World Liberty Financial Inc, a crypto venture launched by Trump and billionaire&nbsp;Steve Witkoff, has teamed up with the&nbsp;Tron&nbsp;crypto platform, Reuters&nbsp;reported on Thursday.
The platform has been&nbsp;associated with groups designated as&nbsp;terrorist organizations, according to financial crime experts. Tron, noted for its speed and cost-effectiveness compared to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has reportedly facilitated crypto transfers linked to such groups.
Last month, Tron announced a $30 million investment in World Liberty, with its founder,&nbsp;Justin Sun, joining as an advisor. Both Sun and World Liberty confirmed this partnership&nbsp;on social media platform X.&nbsp;Concerns have been raised by U.S. government ethics specialists about potential conflicts of interest, given Tron&#8217;s alleged use by militants and Sun&#8217;s ongoing investigation&nbsp;by the U.S. Securities and&nbsp;Exchange Commission.
See Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/24/12/42404450/bitcoin-ethereum-dogecoin-recover-losses-after-flash-crash-analyst-pinpoints-critical-btc-support-levels?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Recover Losses After Flash Crash: Analyst Pinpoints Critical BTC Support Levels</a>
Why It Matters: The partnership between Trump&#8217;s crypto venture and Tron comes at a time when the cryptocurrency industry is hopeful for improved relations with banks. Following Trump&#8217;s election victory, there is optimism that he could <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42434117/trump-would-bridge-the-gap-between-cryptocurrency-and-banks-vcs-hope-still-a-poisoned-chalice-today">bridge the gap </a>between cryptocurrency and traditional banking. Trump has promised to establish a national Bitcoin reserve and a regulatory council, which could potentially ease the banking challenges faced by the crypto sector.
Recently, World Liberty Financial purchased Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) worth $10 million on Wednesday. 
Additionally, Trump&#8217;s potential appointment of&nbsp;Brian Quintenz&nbsp;as head of the Commodity Futures Trading Commission (CFTC) could further influence the regulatory landscape for digital assets. Quintenz, a <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42457774/donald-trump-reportedly-tapping-brian-quintenz-as-head-of-commodity-futures-trading-commission">prominent figure in digital assets</a>, is reportedly a frontrunner for the role. These developments indicate a potential shift in U.S. crypto policy under Trump&#8217;s administration.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42392517/plug-power-awaits-hydrogen-tax-credit-decision-whats-at-stake?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Plug Power Awaits Hydrogen Tax Credit Decision: What&#8217;s At Stake</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Trump-Backed Crypto Venture Partners With Reportedly Controversial Platform

The European Central Bank on Thursday lowered the deposit rate by 25 basis points. The widely-anticipated move marks the ECB&#8217;s fourth interest <a href="https://www.benzinga.com/news/24/10/41379867/european-central-bank-lowers-interest-rates-again-first-back-to-back-cuts-in-13-years">rate cut of the year.&nbsp;</a>
The Details: The Governing Council lowered the interest rates on the deposit facility, the main refinancing operations and the marginal lending facility to 3.00%, 3.15% and 3.40% respectively.&nbsp;
&#8220;Financing conditions are easing, as the Governing Council's recent interest rate cuts gradually make new borrowing less expensive for firms and households,&#8221; the ECB said in a<a href="https://www.ecb.europa.eu/press/pr/date/2024/html/ecb.mp241212~2acab6e51e.en.html"> press release.</a>&nbsp;
&#8220;But they continue to be tight because monetary policy remains restrictive and past interest rate hikes are still transmitting to the outstanding stock of credit.&#8221;
Read More: <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42436676/inflation-rises-as-expected-in-november-sustain-hopes-for-next-weeks-fed-interest-rate-cut">Inflation Rises As Expected In November, Sustains Hopes For December Interest Rate Cut</a>
The ECB said its staff now expect a slower economic recovery than in its September projections, with survey indicators suggesting growth has slowed in the current quarter. 
ECB Staff now see the Eurozone economy growing by 0.7% in 2024, 1.1% in 2025, 1.4% in 2026 and 1.3% in 2027.&nbsp;
The Governing Council said that it will follow a "data-dependent and meeting-by-meeting approach" as it remains determined to ensure inflation stabilizes at its 2% target. It also stressed that it is not committing to any particular rate path going forward.&nbsp;
Markets React: European markets are steady on Thursday as traders assess the ECB&#8217;s interest rate cut. The pan-European Stoxx 600 index was down 0.06% at around 1:30 p.m. London time. Investors will be watching the Xtrackers MSCI Europe Hedged Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBEU#NYSE">DBEU</a>) and the SPDR Portfolio Europe ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPEU#NYSE">SPEU</a>) to gauge the U.S. market reaction to the cuts. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42370672/sofi-makes-spacex-accessible-for-retail-investors">SoFi Unlocks SpaceX Exposure For Retail Investors: Here&#8217;s How</a></li>
</ul>
Image: Shutterstock&nbsp;

Eurozone

Global

ETFs

DBEU

SPEU

European Central Bank Lowers Interest Rates, Fourth Cut In 2024

<a href="https://ml-eu.globenewswire.com/Resource/Download/10e7d669-da68-4b41-a0d3-e7d1e269be82" title="https://ml-eu.globenewswire.com/Resource/Download/10e7d669-da68-4b41-a0d3-e7d1e269be82">https://ml-eu.globenewswire.com/Resource/Download/10e7d669-da68-4b41-a0d3-e7d1e269be82</a>

European Medicines Agency's  Committee For Medicinal Products For Human Use Adopted Positive Opinion For Update Of Novo Nordisk's Ozempic

About the Proposed Transaction
Under the terms of the merger agreement, upon the completion of the Proposed Transaction, Kineta stockholders will receive their pro rata share (based on the number of Kineta fully diluted shares held by them) of aggregate merger consideration consisting of a combination of cash and shares of TuHURA common stock. The cash component of the aggregate merger consideration will be a base cash amount of $9,005,000 (consisting of a value of $15,000,000 minus the $5,995,000 advanced to Kineta under the Exclusivity and Right of First Offer Agreement) less the sum of Kineta's working capital deficit at the closing of the Proposed Transaction and any working capital loans made by TuHURA to Kineta between the signing of the merger agreement and closing of the Proposed Transaction. The share component of the aggregate merger consideration will consist of an aggregate of up to approximately 3,476,568 shares of TuHURA common stock, subject to a six-month holdback of approximately 869,142 of such shares to satisfy certain additional liabilities of the closing date that may be identified after the closing. As additional merger consideration, Kineta stockholders will be entitled to receive their pro rata share of certain payments that Kineta may receive after the closing from the potential pre-closing sale by Kineta of certain non-KVA12123 products and technologies.
In connection with the merger agreement, TuHURA and Kineta entered into a Clinical Trial Funding Agreement under which TuHURA agreed to continue to fund clinical trial expenses for KVA12123 in an amount of up to $900,000, which may be increased upon mutual agreement. The merger agreement also provides that Kineta may request the extension of up to $2,000,000 in working capital loans from TuHURA, $1,750,000 of which will be contingent on the completion of a financing transaction by TuHURA.

HURA

TuHURA Biosciences To Acquire Kineta, Cash Component Of Merger Consideration Will Be Base Cash Amount Of $9,005,000 Less The Sum Of Kineta's Working Capital Deficit At Closing; In Connection With Merger, TuHURA And Kineta Entered Clinical Trial Funding Agreement Under Which TuHURA Agreed To Fund Trial Expenses For KVA12123, Agreement Also Provides That Kineta May Request Extension Of Up To $2M In Working Capital Loans From Tuhura, $1.75M Of Which Will Be Contingent On Completion Of A Financing Transaction

WIIM

FBLG

FibroBiologics shares are trading higher after Rodman & Renshaw initiated coverage on the stock with a Buy rating and announced a price target of $12.

Keybanc analyst Brandon Nispel upgrades Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) from Sector Weight to Overweight and maintains the price target from $500 to $500.

Upgrades

Price Target

Analyst Ratings

CHTR

Keybanc Upgrades Charter Communications to Overweight, Maintains Price Target to $500

A critical vulnerability in the Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) network has led to a significant disruption, with 69% of its nodes rendered inactive. The incident did not meaningfully impact the <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42429730/dogecoins-cycle-peak-projected-8-10-by-top-trader-amid-pullback-but-heres-why-you-should-be-careful">price of Dogecoin.</a>
What Happened: Andreas Kohl, co-founder of the Bitcoin sidechain Sequentia, claimed responsibility for exploiting the flaw on Dec. 12, using a modest laptop in El Salvador to execute the attack.
Prior to the incident, data from Blockchair <a href="https://x.com/EfficiencyDOGE/status/1867008173359718868">showed</a> 647 active Dogecoin nodes.
Following the exploit, that number <a href="https://blockchair.com/dogecoin/nodes">plummeted </a>to 315. Kohl revealed that the exploit leveraged a vulnerability discovered by researcher Tobias Ruck, showcasing a severe gap in the network&#8217;s resilience.
An X account named &#8220;Department of DOGE Efficiency&#8221; had previously <a href="https://x.com/EfficiencyDOGE/status/1864357823163060316">disclosed </a>the existence of the &#8220;DogeReaper&#8221; vulnerability on Dec. 4. 
This results in the operating system halting the program for safety, causing the node to crash.
&#8220;If a malicious actor had discovered this bug instead of us, they could have stopped the Dogecoin network for several days, halting transactions and block creation entirely,&#8221; the account warned.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42457605/exclusive-experts-share-their-top-crypto-predictions-for-2025">EXCLUSIVE: Experts Share Their Top Crypto Predictions For 2025</a>
Why It Matters: The news had no impact on the price of DOGE, which is trading around $0.4138, up 1.8% over the past 24 hours.
According to technical analyst Ali Martinez, Dogecoin could be on the verge of a significant breakout.
Martinez, who has a following of 97,000 on X (formerly Twitter), <a href="https://x.com/ali_charts/status/1866244683661283586">believes</a> DOGE is in the early stages of a bull cycle similar to its 2017 and 2021 runs.
Sharing a chart with his followers, Martinez suggested DOGE is currently trading within a large ascending channel that aligns with historical bull market patterns. 
"Check out where we are in the Dogecoin DOGE bull cycle! Very early, right?" Martinez said. 
He added that he&#8217;s taking advantage of the dip by buying more DOGE in the $0.30–$0.40 range, setting a target of $3 and a speculative upper range of $18 if the market <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">sees a strong rally.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42457774/donald-trump-reportedly-tapping-brian-quintenz-as-head-of-commodity-futures-trading-commission">Donald Trump Reportedly Tapping Brian Quintenz As Head Of Commodity Futures Trading Commission</a></li>
</ul>
Image: Shutterstock

$DOGE

Hacker Exploits Dogecoin Vulnerability, Crashes 69% Of Nodes—But DOGE Still Spikes 1.8%

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 10.16%</li>
<li>RBC Capital analyst Ben Hendrix maintained a Sector Perform rating and cut the price target from $13 to $9 on Dec. 4. This analyst has an accuracy rate of 66%.</li>
<li>Jefferies analyst Brian Tanquilut maintained a Hold rating and cut the price target from $19 to $9 on Oct. 23. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: Walgreens Boots Alliance shares rose Tuesday afternoon following a report suggesting the company is in talks to be acquired by a private-equity firm.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1">latest WBA news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="906" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99.png" alt="" class="wp-image-689505" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99-768x697.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 7.46%</li>
<li>B of A Securities analyst Lisa Lewandowski upgraded the stock from Neutral to Buy and raised the price target from $55 to $65 on Dec. 6. This analyst has an accuracy rate of 62%.</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and raised the price target from $45 to $46 on Nov. 6. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Oct. 31, Altria Group reported better-than-expected third-quarter adjusted EPS results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1">latest MO news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="800" height="777" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100.png" alt="" class="wp-image-689506" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100.png 800w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100-300x291.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100-768x746.png 768w" sizes="(max-width: 800px) 100vw, 800px" /></a></figure>
<h3 class="wp-block-heading">The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)</h3>
<ul>
<li>Dividend Yield: 5.11%</li>
<li>Piper Sandler analyst Michael Lavery downgraded the stock from Overweight to Neutral and cut the price target from $40 to $35 on Nov. 19. This analyst has an accuracy rate of 64%.</li>
<li>Mizuho analyst John Baumgartner maintained an Outperform rating and cut the price target from $43 to $41 on Oct. 31. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On Oct. 30, Kraft Heinz posted third-quarter earnings of 75 cents per share, beating estimates, but reported a revenue decline and anticipates a prolonged recovery in U.S. retail..</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1">trend in KHC stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="928" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101.png" alt="" class="wp-image-689507" style="width:570px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101.png 928w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101-768x701.png 768w" sizes="(max-width: 928px) 100vw, 928px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>

Wall Street's Most Accurate Analysts Weigh In On 3 Risk Off Care Stocks With Over 5% Dividend Yields

COEP

Coeptis Therapeutics shares are trading higher after the company announced the launch of its technologies division and signed a binding letter of intent to acquire the assets from a risk mitigation software company.

Offerings

SPGC

Sacks Parente Golf Prices Upsized $8.4M Underwritten Public Offering Of 7M Common Units At $1.20/Unit

The inflation measured on U.S. producer prices rose more sharply than anticipated in November, marking its second consecutive increase and casting a shadow over the broader outlook for<a href="https://www.benzinga.com/topic/inflation"> disinflation in the economy.</a>
In November, the producer price index increased by 3% year-over-year — the highest since February 2023 — marking a significant uptick from October&#8217;s upwardly revised 2.6% and economist forecasts of 2.6%, as tracked by TradingEconomics.
This official data, released on Thursday, follows a rise in the consumer price index inflation to 2.7% annually last <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42436676/inflation-rises-as-expected-in-november-sustain-hopes-for-next-weeks-fed-interest-rate-cut">month, aligning with estimates.</a>
On a monthly basis, the PPI climbed 0.4%, exceeding both the previous month&#8217;s upwardly revised 0.3% and the forecasted figure of 0.2%. 
Excluding volatile items such as food and energy, the core PPI rose by 3.4% annually, matching an upwardly revised 3.4% in October and above expectations of 3.2%. This marks the fifth consecutive increase in underlying producer prices, with inflation reaching its highest level since June 2024.
On a monthly basis, the core PPI increased by 0.2%, a slight decline from October&#8217;s 0.3%, meeting projections.
Simultaneously, jobless claims rose more than expected to 242,000 for the week ending Dec. 7, surpassing estimates of 220,000. 
<h3 class="wp-block-heading">Producer Prices Are Rising: Why It Matters</h3>
Before the release of the PPI report, investors were nearly fully pricing in an interest rate cut at the Federal Reserve&#8217;s monetary policy meeting next week.
While the robust PPI data is unlikely to halt the widely expected 25-basis-point interest rate cut, it could draw attention during Fed Chair Jerome Powell's press conference, potentially prompting more cautious commentary.
Policymakers aim to maintain consumer prices near the 2% target, but a stronger-than-expected increase in producer input prices could eventually pass through to consumer prices if the trend continues.
<h3 class="wp-block-heading">Market Reactions</h3>
The U.S. Dollar Index (DXY), tracked through the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), rose 0.1% following the report. 
Session gains for the greenback were further supported by an interest rate cut from the European Central Bank. 
The ECB reduced its interest rate by 25 basis points to 3%, as widely anticipated. This decision drove the euro-dollar exchange rate below the 1.05 level.
Treasury yields remained steady after the PPI report, as the upward impact from hotter inflation was simultaneously counterbalanced by downward pressure from rising jobless claims. 
U.S. equity futures turned negative in premarket trading in New York. Futures contracts for the S&amp;P 500 fell 0.4%, reflecting heightened investor caution.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42456905/us-stocks-to-open-lower-despite-strong-probability-of-upcoming-fed-rate-cut-market-breadth-skewed-in-the-favor-of-bears-over-the-last-seven-session">Wall Street Poised To Open Lower A Day After Nasdaq&#8217;s Record Close Above 20,000: Expert Flags &#8216;Deterioration Under The Surface&#8217; As 117 S&amp;P 500 Stocks Hit New Monthly Lows</a></li>
</ul>
Photo via Shutterstock.

Equities

Bonds

Currency ETFs

Treasuries

Econ #s

Economics

Federal Reserve

PowerShares DB US Dollar Index Bullish Fund

Producer Inflation Rises More Than Expected To 3% In November: All Eyes On The Fed's Interest Rate Call

GSAT

Globalstar Announces The First 5G Data Call In Globalstar Band n53 Spectrum

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/12/11/final-trades-meta-rockwell-zoom-video-and-the-xlu.html">Halftime Report Final Trades</a>,&#8221; Rob Sechan of NewEdge Wealth said Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) continues its near-term momentum.
Meta CEO Mark Zuckerberg sold approximately $88 million worth of company stock over the past week, according to regulatory filings with the U.S. Securities and <a href="https://www.benzinga.com/24/12/42454694/meta-ceo-mark-zuckerberg-sells-88m-in-shares-amid-stocks-2024-surge-of-82">Exchange Commission (SEC) on Wednesday</a>.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a> 
Stephanie Link of Hightower picked Rockwell Automation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>) <a href="https://www.benzinga.com/quote/ROK/analyst-ratings">as her final trade.</a>
On Monday, Keybanc analyst Ken Newman upgraded Rockwell Automation from Sector Weight to Overweight and maintained the price target of $345. Citigroup analyst Andrew Kaplowitz maintained the stock with a Buy and raised the price target from $313 to $345.
Shannon Saccocia of NB Private Wealth named The Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) as her final trade.
Joseph M. Terranova of Virtus Investment Partners picked Zoom Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>).
On Nov. 25, Zoom reported third-quarter revenue of $1.18 billion, beating the consensus estimate of $1.16 billion. The communications company reported third-quarter adjusted earnings of $1.38 per share, beating analyst estimates of $1.31 per share. 
Zoom expects fiscal&nbsp;fourth-quarter&nbsp;revenue to be in the range of&nbsp;$1.175&nbsp;billion&nbsp;to&nbsp;$1.18 billion&nbsp;versus estimates of&nbsp;$1.17 billion. The company sees&nbsp;fourth-quarter&nbsp;adjusted earnings of&nbsp;$1.29&nbsp;to&nbsp;$1.30&nbsp;per share versus <a href="https://www.benzinga.com/news/management/24/11/42176089/zoom-communications-q3-earnings-revenue-beat-eps-beat-online-churn-hits-all-time-low-company-name-change-and-more">estimates of&nbsp;$1.28&nbsp;per share.&nbsp;</a>
Price Action:
<ul>
<li>Rockwell Automation shares gained by 1.3% to close at $297.38 on Wednesday.</li>
<li>Meta shares gained by 2.2% to settle at $632.68 during Wednesday's session.</li>
<li>The Utilities Select Sector SPDR Fund fell 0.6% during Wednesday's session.</li>
<li>Zoom shares gained 3.3% to close at $86.59.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>
Image: Shutterstock

Meta, Zoom, Rockwell Automation And More On CNBC's 'Final Trades'

IVAC

Intevac shares are trading higher after the company provided business updates including its year-end cash balance, projects $200 million in revenue over the next three years, and will commence a quarterly dividend of $0.05 per share beginning in Q1 2025.

ACHR

Archer shares are trading higher after the company announced a partnership with Anduril to develop hybrid VTOL military aircraft and reported raising an additional $430 million in equity capital.

In the current market session, FirstEnergy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FE#NYSE">FE</a>) share price is at $40.42, after a 0.75% spike. Moreover, over the past month, the stock decreased by 1.74%, but in the past year, spiked by 8.49%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1734011192_0.png" alt="Past Year Chart" />

<h3>Comparing FirstEnergy P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 17.74 in the Electric Utilities industry, FirstEnergy Inc. has a higher P/E ratio of 25.88. Shareholders might be inclined to think that FirstEnergy Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734011192_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: FirstEnergy

Coincheck Group

Comments

Coincheck Group

Actualités

Dernières nouvelles pour Coincheck Group (NASDAQ:CNCK) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL